Reducing sodium intake did not lead to a reduction in death/hospitalization in ambulatory patients with heart failure in the SODIUM-HF study, although symptoms appeared to improve.
Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
The liver is one of the body's most crucial organs, responsible for detoxifying the blood, metabolizing macronutrients, and producing chemicals that enable essential bodily processes. And during this pandemic, many of us are not treating it properly: "Although national figures are not available, admissions for alcoholic liver disease at Keck Hospital of the University of Southern California were up 30% in 2020 compared with 2019, said Dr. Brian Lee, a transplant hepatologist who treats the condition in alcoholics," reports Kaiser Health News. “There’s been a tremendous influx,” Dr. Haripriya Maddur, a hepatologist at Northwestern Medicine, told the website. Read on to see the #1 danger sign—and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had Coronavirus.The #1 Danger Sign Your Liver Is in Trouble is Fluid RetentionIf your liver isn't functioning properly, it can cause serious, even
Share this article
Share this article
RARITAN, N.J., Feb. 8, 2021 /PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA
® and ZYTIGA
® plus prednisone (control arm).
1 Results will be featured in an oral presentation at the American Society of Clinical Oncology s Genitourinary (ASCO GU) Cancers Symposium, taking place virtually February 11-13, 2021 (Abstract #9; Oral Abstract Session: Prostate Cancer, February 11, 12:45 PM-2:00 PM EST).